Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Durham

Showing results (91-100 of 240) with videos related to

Pageof 24
Sort By:
Springer Seminars in Immunopathology|January 1, 1993
Evidence for Th2-type T helper cell control of allergic disease in vivoD S Robinson, Q Hamid, M Jacobson, et al.
Allergy|December 5, 2012
Efficacy and safety of the SQ-standardized grass allergy immunotherapy tablet in mono- and polysensitized subjectsH Nelson, M Blaiss, H Nolte, et al.
International Archives of Allergy and Applied Immunology|January 1, 1987
Acid anhydrides and asthmaA J Taylor, K M Venables, S R Durham, et al.
The European Respiratory Journal|December 1, 1996
Increased expression of mRNA encoding RANTES and MCP-3 in the bronchial mucosa in atopic asthmaN Powell, M Humbert, S R Durham, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1992
Preferential messenger RNA expression of Th1-type cells (IFN-gamma+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skinA Tsicopoulos, Q Hamid, V Varney, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 23, 2009
Time course of serum inhibitory activity for facilitated allergen-IgE binding during bee venom immunotherapy in childrenE-M Varga, J N Francis, M S Zach, et al.
Allergy|March 29, 2014
Dropouts in sublingual allergen immunotherapy trials - a systematic reviewM Makatsori, G W Scadding, C Lombardo, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 21, 2000
Cytokine expression during allergen-induced late nasal responses: IL-4 and IL-5 mRNA is expressed early (at 6 h) predominantly by eosinophilsK T Nouri-Aria, F O'Brien, W Noble, et al.
Lancet (London, England)|November 26, 1983
Complement receptor enhancement as evidence of neutrophil activation after exercise-induced asthmaN Papageorgiou, M Carroll, S R Durham, et al.
American Journal of Respiratory Cell and Molecular Biology|July 1, 1997
IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapyO Ghaffar, S Laberge, M R Jacobson, et al.
Pageof 24

Showing results (91-100 of 240) with videos related to

Sort By:
Pageof 24
Springer Seminars in Immunopathology|January 1, 1993
Evidence for Th2-type T helper cell control of allergic disease in vivoD S Robinson, Q Hamid, M Jacobson, et al.
Allergy|December 5, 2012
Efficacy and safety of the SQ-standardized grass allergy immunotherapy tablet in mono- and polysensitized subjectsH Nelson, M Blaiss, H Nolte, et al.
International Archives of Allergy and Applied Immunology|January 1, 1987
Acid anhydrides and asthmaA J Taylor, K M Venables, S R Durham, et al.
The European Respiratory Journal|December 1, 1996
Increased expression of mRNA encoding RANTES and MCP-3 in the bronchial mucosa in atopic asthmaN Powell, M Humbert, S R Durham, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1992
Preferential messenger RNA expression of Th1-type cells (IFN-gamma+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skinA Tsicopoulos, Q Hamid, V Varney, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 23, 2009
Time course of serum inhibitory activity for facilitated allergen-IgE binding during bee venom immunotherapy in childrenE-M Varga, J N Francis, M S Zach, et al.
Allergy|March 29, 2014
Dropouts in sublingual allergen immunotherapy trials - a systematic reviewM Makatsori, G W Scadding, C Lombardo, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 21, 2000
Cytokine expression during allergen-induced late nasal responses: IL-4 and IL-5 mRNA is expressed early (at 6 h) predominantly by eosinophilsK T Nouri-Aria, F O'Brien, W Noble, et al.
Lancet (London, England)|November 26, 1983
Complement receptor enhancement as evidence of neutrophil activation after exercise-induced asthmaN Papageorgiou, M Carroll, S R Durham, et al.
American Journal of Respiratory Cell and Molecular Biology|July 1, 1997
IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapyO Ghaffar, S Laberge, M R Jacobson, et al.
Pageof 24